Inventor
KORSMEYER STANLEY J
US32 patents
⚠️ This page may combine multiple inventors who share the name “KORSMEYER STANLEY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV WASHINGTON
15 patentsUS5998583ADec 7, 1999
BH3 interacting domain death agonist
UNIV WASHINGTON113 citations99
US5856445AJan 5, 1999
Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator
UNIV WASHINGTON169 citations99
US5955593ASep 21, 1999
BH3 interacting domain death agonist
UNIV WASHINGTON100 citations98
US5834209ANov 10, 1998
Bcl-x/bcl-2 associated cell death regulator
UNIV WASHINGTON81 citations96
US5691179ANov 25, 1997
Cell death regulators
UNIV WASHINGTON45 citations96
US5622852AApr 22, 1997
Bcl-x/Bcl-2 associated cell death regulator
UNIV WASHINGTON84 citations96
US6326354B1Dec 4, 2001
Modulation of apoptosis with bid
UNIV WASHINGTON84 citations93
US5856171AJan 5, 1999
Cell death regulators
UNIV WASHINGTON32 citations92
US6165732ADec 26, 2000
Method for identifying apoptosis modulating compounds
UNIV WASHINGTON24 citations91
US5955595ASep 21, 1999
Cell death regulators
UNIV WASHINGTON11 citations82
US6500626B1Dec 31, 2002
Cell death regulators
UNIV WASHINGTON4 citations74
US5700638ADec 23, 1997
Cell death regulator
UNIV WASHINGTON6 citations74
US6184202B1Feb 6, 2001
Cell death regulators
UNIV WASHINGTON2 citations63
US5942490AAug 24, 1999
Cell death regulators
UNIV WASHINGTON2 citations63
US5850002ADec 15, 1998
Animal models for loss and gain of Hox11 function
UNIV WASHINGTON1 citations52
DANA FARBER CANCER INST INC
11 patentsUS7723469B2May 25, 2010
Stabilized alpha helical peptides and uses thereof
DANA FARBER CANCER INST INC151 citations98
US7868133B2Jan 11, 2011
BH3 peptides and method of use thereof
DANA FARBER CANCER INST INC46 citations97
US7247700B2Jul 24, 2007
BID polypeptides and methods of inducing apoptosis
DANA FARBER CANCER INST INC82 citations95
US9902759B2Feb 27, 2018
BH3 peptides and methods of use thereof
DANA FARBER CANCER INST INC25 citations93
US9527896B2Dec 27, 2016
Stabilized p53 peptides and uses thereof
DANA FARBER CANCER INST INC31 citations93
US9464115B2Oct 11, 2016
Stabilized alpha helical peptides and uses thereof
DANA FARBER CANCER INST INC29 citations93
US7011947B2Mar 14, 2006
MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
DANA FARBER CANCER INST INC24 citations92
US7829662B2Nov 9, 2010
Method of treating apoptosis and compositions thereof
DANA FARBER CANCER INST INC28 citations89
US11225511B2Jan 18, 2022
BH3 peptides and methods of use thereof
DANA FARBER CANCER INST INC4 citations83
US10202431B2Feb 12, 2019
Stabilized P53 peptides and uses thereof
DANA FARBER CANCER INST INC6 citations83
US7964700B2Jun 21, 2011
Inhibitors of Taspase1 protease activity
DANA FARBER CANCER INST INC1 citations40
WALENSKY LOREN D
3 patentsUS8796418B2Aug 5, 2014
Stabilized alpha helical peptides and uses thereof
WALENSKY LOREN D73 citations98
US9273099B2Mar 1, 2016
Stabilized alpha helical peptides and uses thereof
WALENSKY LOREN D35 citations97
US8198405B2Jun 12, 2012
Stabilized alpha helical peptides and uses thereof
WALENSKY LOREN D67 citations94